Personalized Medicine

Papers
(The H4-Index of Personalized Medicine is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension65
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients29
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness22
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population17
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia16
An evidence gap map of the personalized medicine in bladder cancer15
Pharmacogenomics education in China and the United States: advancing personalized medicine14
Perceived understanding and psychosocial outcomes: employees’ responses to learning results of workplace genetic testing12
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis10
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease9
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls9
0.040656089782715